The peptide therapy market is projected to reach $54.62 billion globally in 2026, with compounding pharmacies growing at a 28% annual rate and telehealth accounting for 67% of all U.S. peptide prescriptions. For entrepreneurs and clinicians watching these numbers, the question is no longer whether to enter the market. It is how fast you can get there.
Building a peptide telehealth clinic from scratch requires assembling compounding pharmacy contracts, credentialing providers across multiple states, building HIPAA-compliant software, integrating payment processing, and navigating state-by-state telehealth regulations. That process takes months and significant capital.
A turnkey peptide telehealth platform eliminates that timeline. This guide covers what turnkey means in practice, what the infrastructure actually looks like, and how to evaluate whether a platform can support a real business.
What “Turnkey” Actually Means in Peptide Telehealth
The term gets used loosely, so here is what a genuinely turnkey peptide telehealth platform should provide:
Clinical infrastructure. A licensed provider network covering all 50 states that handles patient evaluations, prescribing decisions, and clinical documentation. The operator does not need a medical license. Providers review patient intake forms, assess eligibility, and prescribe appropriate peptide therapies under their own clinical authority.
Pharmacy fulfillment. Direct integrations with compounding pharmacies. When a provider approves a prescription, it routes automatically to a pharmacy partner. The pharmacy compounds the medication, packages it, and ships it directly to the patient. No manual faxing, no phone calls, no inventory management.
Patient intake and workflow. Digital intake forms that collect medical history, screen for contraindications, flag safety concerns, and route patients to the appropriate clinical pathway. A well-built system handles this asynchronously so patients can complete intake on their own time and providers review cases in a structured queue.
HIPAA-compliant technology. Encrypted data storage, secure patient portals, audit logging, and signed Business Associate Agreements (BAAs) with every vendor in the chain. This is non-negotiable in healthcare.
Checkout. An integrated checkout connected to the operator’s own payment processor, with subscription billing for ongoing programs. Patients pay the operator directly, and on Karpa there is no revenue share.
Branding and customization. At minimum, white-label capability so patients see the operator’s clinic name and branding rather than the platform behind it.
If any of these pieces are missing, it is not truly turnkey. It is a partial solution that will require you to build and manage the gaps.
The Regulatory Landscape: Why Timing Matters
FDA Peptide Categories
In September 2023, the FDA placed 19 commonly used peptides on the Category 2 list, restricting compounding pharmacies from preparing them. In April 2026 FDA removed many of them from Category 2 after their nominations were withdrawn, but that did not make them eligible: BPC-157, CJC-1295/Ipamorelin, and TB-500 / Thymosin Beta-4 are not on the FDA’s 503A bulks list or in Category 1, so they cannot be compounded or offered. Compliant programs are built on compoundable peptides such as Sermorelin and PT-141. For a deeper breakdown, see our peptide therapy program page.
What This Means for Clinic Operators
Compoundable peptide programs can launch now. Practices with their infrastructure in place can start treating patients right away, while those still assembling custom systems will be months behind.
This is the core advantage of a turnkey approach: the pharmacy relationships, provider protocols, and intake workflows are already built, and when FDA guidance changes, a turnkey platform can update its program menu across all its clinics at once.
Telehealth Prescribing Requirements
Telehealth prescribing of compounded peptides follows the same regulatory framework as any telehealth prescription. Key requirements include:
- State licensure. The prescribing provider must hold an active medical license in the state where the patient is physically located. A 50-state provider network solves this automatically.
- Patient-provider relationship. Most states require a real-time clinical evaluation via video or audio. Some states accept asynchronous review for non-controlled substances, which includes all currently available peptides.
- Informed consent. Specific telehealth consent covering the nature of remote care, privacy protections, and the patient’s right to seek in-person treatment.
The Federation of State Medical Boards (FSMB) maintains a telehealth policy tracker that covers state-by-state requirements. For a detailed breakdown, see our guide on telehealth prescribing for peptides.
Anatomy of a Turnkey Peptide Telehealth Platform
Understanding the components helps you evaluate what you are actually getting.
Provider Network
The provider network is the clinical backbone. A turnkey platform should supply:
- Multi-state coverage. Providers licensed in all 50 states so you can serve patients anywhere in the U.S. without geographic limitations.
- Clinical protocols. Standardized treatment protocols for each peptide program. These protocols define intake questions, contraindication screening, prescribing criteria, dosing guidelines, and follow-up schedules.
- Asynchronous and synchronous options. Asynchronous review (provider reviews intake form and prescribes without a live call) is faster and cheaper. Synchronous consultations (video or phone) are required in some states and for some clinical scenarios. The platform should support both.
Pharmacy Integration
The pharmacy layer determines how reliably patients receive their medications. Look for:
- Direct API integration with a compounding pharmacy. This means prescriptions are transmitted electronically, not faxed. Order status, tracking numbers, and shipping updates flow back to the platform automatically.
- 503A pharmacy access. Karpa’s pharmacy partner is a licensed 503A pharmacy with a broad peptide formulary and direct-to-patient shipping. The operator never handles inventory.
- Direct-to-patient shipping. Medications ship from the pharmacy directly to the patient, which eliminates storage requirements, cold chain logistics, and compliance concerns for the operator.
For more on pharmacy selection, see our guide on choosing a compounding pharmacy partner.
Patient Intake and Clinical Workflow
The intake system is where patient experience meets clinical rigor. A good system includes:
- Structured questionnaires that collect relevant medical history, current medications, allergies, and health goals.
- Automated screening that flags contraindications and safety concerns before a provider ever sees the case. This saves provider time and catches issues early.
- Treatment selection that lets patients choose their program and preferred medication within clinically appropriate options.
- Document collection for items like photo ID verification, which is required for prescribing in many states.
- Asynchronous submission so patients complete intake on their schedule, not during a scheduled appointment window.
For a detailed look at intake design, see our guide on patient intake workflow for peptide clinics.
HIPAA Compliance and Security
Healthcare data requires infrastructure-level security, not just surface-level measures. A compliant platform should provide:
- 256-bit AES encryption for data at rest and TLS 1.2+ for data in transit
- Signed BAAs with every vendor that touches patient data (platform, pharmacy, payment processor, cloud provider)
- Audit logging for every data access event, so you can trace who viewed what and when
- Role-based access controls that limit data visibility based on user type (operator, provider, patient)
- SOC 2 or equivalent security certification
For a full compliance checklist, see our HIPAA compliance guide for cash-pay programs.
Business Models: How Turnkey Peptide Clinics Make Money
There are two ways in: refer patients to an existing clinic as an affiliate, or run your own clinic. Many operators start as affiliates and graduate to their own clinic once they see demand.
Affiliate or Referral Model
The lowest barrier to entry. On Karpa Health, you apply to be an affiliate for a partner’s Full Clinic and refer patients to that existing clinic. When a patient enrolls through your link, you earn a recurring payout.
- Setup cost: Free to apply, no license required
- Revenue: Recurring referral payouts on the patients you send
- What you handle: Marketing and patient acquisition
- What the partner clinic handles: Everything else
Best for influencers, coaches, gym owners, and wellness professionals with an existing audience who are not ready to run their own clinic. No operational responsibility, no medical complexity, no compliance burden beyond honest marketing.
Full Clinic
The full operator model. The clinic runs on the operator’s own domain with complete white-label branding. The operator controls pricing and owns and manages the patient relationship directly.
- Cost: Plans start at $297/mo plus a one-time implementation fee. Start on Launch to validate demand (3 programs, up to 50 active patients per month), then move up to Growth (6 programs, unlimited patients, custom lab panels) and Scale (every program, branded at-home lab testing (coming soon), first access to new programs) as you grow
- Revenue: Operator keeps all patient revenue minus platform fees, provider consultation fees, and pharmacy costs (passed through at cost, no revenue share)
- What you handle: Marketing, pricing, patient communication, brand, business operations
- What the platform handles: Provider network, pharmacy integration, clinical workflow, compliance infrastructure
Best for entrepreneurs building a scalable telehealth brand with enterprise value. This model creates a real business asset because you own the patient relationships and the revenue.
The Economics: Why Peptide Telehealth Margins Are Attractive
Peptide therapy programs typically operate with strong unit economics.
A typical GLP-1 weight loss program charges patients $199 to $399 per month. Compounding pharmacy costs for a month’s supply of compounded semaglutide run $35 to $80 depending on dosage and pharmacy. Provider consultation fees run $30 to $60 per completed consult, and most patients only need one consultation every 90 days.
For a Full Clinic operator charging $249 per month:
- Patient pays: $249
- Pharmacy cost: ~$50
- Consultation cost: ~$15/month (amortized from $45 per quarterly consult)
- Platform fee: ~$6/month per patient ($297/month Launch plan spread across 50 active patients)
- Gross margin per patient: ~$178/month (71%)
At 50 active patients, that is roughly $8,900 per month in gross profit. The Launch plan covers up to 50 active patients; above that you move to the Growth plan, which we price on the call.
For more context on program economics, read our startup costs guide.
What to Look for When Evaluating a Turnkey Platform
Not all turnkey platforms are equivalent. Here is a checklist for evaluation:
Clinical Quality
- Does the platform provide its own licensed provider network, or do you need to source providers?
- Are clinical protocols evidence-based and regularly updated?
- How does the platform handle adverse events or clinical escalations?
- What is the average case review turnaround time?
Pharmacy Reliability
- How many pharmacy partners are integrated?
- Are integrations API-based (electronic) or manual (fax/phone)?
- What happens if a pharmacy is out of stock on a specific peptide?
- How is shipping tracked and communicated to patients?
Technology and Compliance
- Can the platform provide a signed BAA?
- Is the infrastructure SOC 2 certified or equivalent?
- Does the platform support both asynchronous and synchronous consultations?
- Is the patient intake mobile-friendly?
- Does the platform integrate with marketing tools (email, ad pixels, analytics)?
Business Flexibility
- Can you control your own pricing?
- Do you own your patient data, and can you export it?
- Can you upgrade plans as you grow without losing patient history?
- What are the contract terms, and is there lock-in?
Support and Onboarding
- How long does it take to go live?
- Is there a dedicated onboarding process?
- What kind of ongoing support is available (email, chat, phone)?
- Does the platform help with compliance updates when regulations change?
Common Mistakes to Avoid
Choosing on price alone. The cheapest platform might cut corners on compliance, use a single pharmacy partner, or lack a real provider network. In healthcare, those shortcuts create liability.
Ignoring pharmacy redundancy. If your only pharmacy partner has a supply disruption, your patients get no medication. Multiple pharmacy integrations are not a luxury feature; they are business continuity.
Underestimating compliance. The Ryan Haight Act governs online prescribing of controlled substances. While most peptides are not controlled, testosterone (commonly paired with peptide programs) is Schedule III. Make sure the platform handles this correctly.
Not building an audience first. A turnkey platform handles operations, not marketing. If you have no audience, no email list, no social following, and no referral network, even the best platform will not generate patients for you. Start building your audience before or during your platform setup.
Waiting for regulatory certainty. Regulatory frameworks in peptide therapy are evolving. Waiting for perfect clarity means missing the window while competitors establish market position. Choose a platform that actively monitors and adapts to regulatory changes so you can launch with confidence.
Next Steps
If you are evaluating turnkey peptide telehealth platforms, start with these questions:
-
What model fits your situation? If you have an audience but are not ready to run a clinic, becoming an affiliate for a partner clinic lets you start earning immediately. If you want to build a scalable clinic business, a Full Clinic gives you ownership and margin.
-
What programs will you offer? Peptide therapy, GLP-1 weight loss, testosterone replacement, and hormone therapy are the most common starting points. Many operators launch with one program and expand as they grow.
-
How quickly do you want to launch? If the answer is in about 7 days, you need your own website and LegitScript certification already in place and a platform with existing pharmacy relationships, an active provider network, and a proven onboarding process. Building custom infrastructure is not an option at that timeline.
Karpa Health provides turnkey peptide telehealth infrastructure through its Full Clinic plans (Launch, Growth, and Scale), plus an affiliate path for people who want to refer patients to a partner’s clinic first. The platform includes a 50-state licensed provider network, direct integration with a licensed 503A compounding pharmacy, automated patient intake, and HIPAA-compliant infrastructure.
Book a free walkthrough to see how the platform works and get a personalized launch plan for your peptide therapy program.
For the full launch sequence - legal structure, model choice, costs, and the first patients - read how to start a peptide telehealth business.
